Magnazide-TZ 281.25 mg Injection
Composition : Ceftazidime 250 mg & Tazobactam 31.25 mg
Read MoreTherapeutic Segment : Antibiotic | Anti-Infective
Packing : Vial + 5 ml bottle in mono carton WFI
Dosage : In children 30 to 100 mg/kg daily in 2 or 3 divided doses
Product Information
Magnazide-TZ Injection is used to treat bacterial infections. It combines Ceftazidime, a broad-spectrum antibiotic, and Tazobactam, a beta-lactamase inhibitor, to enhance the effectiveness of the treatment by reducing bacterial resistance.
- Intra-abdominal infections
- Burns and wounds
- Serious ICU infections
- Severe LRTI’s
- Complicated UTI’s & SSTI’s
- Bone & Joint Infections
- Meningitis
- Bacterial Septicemia
- Doctor or nurse will give you this medicine.
- Kindly do not self-administer.
Ceftazidime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Tazobactum is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Ceftazidime against bacteria.
Magnazide 1 gm Injection | Magnazide 250 mg Injection
Magnazide-TZ 1.125 gm Injection | Magnazide-TZ 281.25 mg Injection
